Please assess the completion status of the following clinical trial:

Trial Title: VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy adults~* Males or non-pregnant, non-lactating females~* Body Mass Index (BMI) between 18.5 - 32.0, inclusive.~* Suitable veins for cannulation~Exclusion Criteria:~* Employee of site or the sponsor~* Any disease that poses an unacceptable risk to participants~* Abnormal ECG~* Abnormal labs~* Abnormal vital signs~* Current cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, autoimmune, hematologic, neoplastic, or neurological disorder~* Positive serology for hepatitis B surface antigen, hepatitis C antibody, or human immunodeficiency virus (HIV) type 1~* Current smokers or history of smoking within 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- VNRX-5133 (Type: EXPERIMENTAL): IV infusion
- Placebo (Type: PLACEBO_COMPARATOR): IV infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).